CBOE Holdings Earnings Calls
| Release date | Oct 31, 2025 |
| EPS estimate | $2.53 |
| EPS actual | $2.67 |
| EPS Surprise | 5.53% |
| Revenue estimate | 614.19M |
| Revenue actual | 1.142B |
| Revenue Surprise | 85.89% |
| Release date | Aug 01, 2025 |
| EPS estimate | $2.42 |
| EPS actual | $2.46 |
| EPS Surprise | 1.65% |
| Revenue estimate | 574.304M |
| Revenue actual | 1.174B |
| Revenue Surprise | 104.33% |
| Release date | May 02, 2025 |
| EPS estimate | $2.36 |
| EPS actual | $2.50 |
| EPS Surprise | 5.93% |
| Revenue estimate | 560.718M |
| Revenue actual | 1.195B |
| Revenue Surprise | 113.12% |
| Release date | Feb 07, 2025 |
| EPS estimate | $2.13 |
| EPS actual | $2.10 |
| EPS Surprise | -1.41% |
| Revenue estimate | 530.682M |
| Revenue actual | 1.108B |
| Revenue Surprise | 108.71% |
Last 4 Quarters for CBOE Holdings
Below you can see how CBOE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 07, 2025 |
| Price on release | $211.17 |
| EPS estimate | $2.13 |
| EPS actual | $2.10 |
| EPS surprise | -1.41% |
| Date | Price |
|---|---|
| Feb 03, 2025 | $209.55 |
| Feb 04, 2025 | $209.19 |
| Feb 05, 2025 | $208.28 |
| Feb 06, 2025 | $207.00 |
| Feb 07, 2025 | $211.17 |
| Feb 10, 2025 | $209.71 |
| Feb 11, 2025 | $208.00 |
| Feb 12, 2025 | $212.04 |
| Feb 13, 2025 | $208.23 |
| 4 days before | 0.773% |
| 4 days after | -1.39% |
| On release day | -0.691% |
| Change in period | -0.630% |
| Release date | May 02, 2025 |
| Price on release | $226.39 |
| EPS estimate | $2.36 |
| EPS actual | $2.50 |
| EPS surprise | 5.93% |
| Date | Price |
|---|---|
| Apr 28, 2025 | $212.19 |
| Apr 29, 2025 | $217.05 |
| Apr 30, 2025 | $221.80 |
| May 01, 2025 | $221.21 |
| May 02, 2025 | $226.39 |
| May 05, 2025 | $231.67 |
| May 06, 2025 | $233.32 |
| May 07, 2025 | $234.23 |
| May 08, 2025 | $228.66 |
| 4 days before | 6.69% |
| 4 days after | 1.00% |
| On release day | 2.32% |
| Change in period | 7.76% |
| Release date | Aug 01, 2025 |
| Price on release | $247.59 |
| EPS estimate | $2.42 |
| EPS actual | $2.46 |
| EPS surprise | 1.65% |
| Date | Price |
|---|---|
| Jul 28, 2025 | $241.67 |
| Jul 29, 2025 | $239.32 |
| Jul 30, 2025 | $241.68 |
| Jul 31, 2025 | $241.04 |
| Aug 01, 2025 | $247.59 |
| Aug 04, 2025 | $250.87 |
| Aug 05, 2025 | $248.79 |
| Aug 06, 2025 | $248.10 |
| Aug 07, 2025 | $249.50 |
| 4 days before | 2.45% |
| 4 days after | 0.771% |
| On release day | 1.32% |
| Change in period | 3.24% |
| Release date | Oct 31, 2025 |
| Price on release | $246.10 |
| EPS estimate | $2.53 |
| EPS actual | $2.67 |
| EPS surprise | 5.53% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $238.27 |
| Oct 28, 2025 | $238.53 |
| Oct 29, 2025 | $232.68 |
| Oct 30, 2025 | $237.10 |
| Oct 31, 2025 | $246.10 |
| Nov 03, 2025 | $246.92 |
| Nov 04, 2025 | $250.26 |
| Nov 05, 2025 | $251.40 |
| Nov 06, 2025 | $252.75 |
| 4 days before | 3.29% |
| 4 days after | 2.70% |
| On release day | 0.333% |
| Change in period | 6.08% |
CBOE Holdings Earnings Call Transcript Summary of Q3 2025
Cboe reported a strong Q3 with record net revenue of $605.5M (up 14% YoY) and adjusted diluted EPS of $2.67 (up 20% YoY). Growth was broad-based: Derivatives (+15%) led by record SPX activity and dramatic 0DTE growth, Cash & Spot (+14%) led by Europe, and Data Vantage (+12%) driven largely by new unit sales and international uptake. Management completed a strategic portfolio review and announced a realignment: initiate sales processes for Cboe Australia and Cboe Canada, discontinue U.S. and European Corporate Listings efforts, reduce costs in certain ETP Listings, Cboe Europe Derivatives Exchange and smaller Risk/Market Analytics businesses, and complete prior wind-down of Japanese equities. Management expects the combined actions to be accretive to earnings, with an estimated ~3% reduction in net revenue and an 8–10% reduction in adjusted operating expenses (annualized run rate vs 2025 guidance baseline), and said the moves free up human and modest capital resources to double down on core growth areas: index & multi-list options, futures, US/European equities, FX, Data Vantage, plus emerging opportunities in event/prediction markets, retail expansion, digital/crypto products and extended trading hours. Financial position remains healthy (adjusted cash ~$1.5B, leverage ~1.0x), Moody's upgraded the rating to A2, and management raised full-year 2025 total organic net revenue growth guidance to low double-digit to mid-teens and narrowed/lowered expense and CapEx ranges. Management emphasized disciplined expense control while reserving flexibility to invest in selective, mostly low-capital growth initiatives.
Sign In
Buy CBOE